A review of patient-reported outcome assessments in registration trials of FDA-approved new oncology drugs (2014-2018).
Contemp Clin Trials
; 120: 106860, 2022 09.
Article
in En
| MEDLINE
| ID: mdl-35901962
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Drug Approval
/
Neoplasms
Type of study:
Clinical_trials
Aspects:
Patient_preference
Limits:
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
Contemp Clin Trials
Journal subject:
MEDICINA
/
TERAPEUTICA
Year:
2022
Document type:
Article
Country of publication:
United States